Clinical Trial Update: A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two doses of Fluticasone Furoate Nasal Spray in Chinese pediatric subjects with allergic rhinitis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Fluticasone furoate nasal spray (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal, Rhinitis, Allergic | Phase 4 | Status: COMPLETED | Results posted: 2019-02-06